HCA Healthcare, Inc. $HCA Shares Sold by Abrams Bison Investments LLC

Abrams Bison Investments LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 35.8% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 255,000 shares of the company’s stock after selling 142,000 shares during the quarter. HCA Healthcare comprises approximately 9.1% of Abrams Bison Investments LLC’s holdings, making the stock its 5th largest holding. Abrams Bison Investments LLC’s holdings in HCA Healthcare were worth $97,690,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Clearstead Trust LLC raised its position in HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth about $27,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at about $26,000. Finally, WPG Advisers LLC purchased a new position in HCA Healthcare in the 1st quarter worth approximately $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Cowen reissued a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Jefferies Financial Group raised their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Finally, Robert W. Baird upped their target price on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $475.95.

HCA Healthcare Stock Performance

NYSE HCA opened at $484.67 on Friday. The company has a 50-day simple moving average of $465.59 and a 200-day simple moving average of $413.62. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00. The firm has a market capitalization of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.